Handelsbanken Fonder
HCAT icon

Handelsbanken Fonder’s Health Catalyst HCAT Stock Holding History

Handelsbanken Fonder’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,800
Closed -$318K – 1719
2021
Q1 		$318K Buy
+6,800
New +$329K ﹤0.01% 1421

Other funds holding HCAT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Handelsbanken Fonder's HCAT Position: Q2 2021 in Review

Handelsbanken Fonder sold out of Health Catalyst (HCAT) in Q2 2021, closing a stake of 6,800 shares — an estimated $318K sold.

Handelsbanken Fonder first reported a position in HCAT in Q1 2021 and held it in 1 quarter. The position peaked at $318K in Q1 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

  • Handelsbanken Fonder reported no remaining Health Catalyst position as of Q2 2021 after selling out during the quarter.
  • Handelsbanken Fonder sold 6,800 Health Catalyst shares in Q2 2021, an estimated $318K.
  • Handelsbanken Fonder first reported a position in Health Catalyst in Q1 2021 and held it in 1 quarter.
  • Handelsbanken Fonder's Health Catalyst position peaked at $318K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on Handelsbanken Fonder's 13F filing for Q2 2021, filed 3 Aug 2021.